EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Sphenopalatine ganglion block for pain control after septoplasty: a systematic review and meta-analysis with trial sequential analysis

E Albazee, B AlRajhi, A Alfadhli, A M Alharran, M Al-Qudah

Rhinology Journal · 2024

DOI: 10.4193/rhin24.225 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Rhinology Journal, 2024. Verfasst von E Albazee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Kuwait Institute for Medical Specializations (KIMS), Kuwait City, Kuwait. Hauptthemen laut MEDLINE: Sphenopalatine Ganglion Block, Postoperative Pain, Nasal Septum. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Septoplasty corrects a deviated nasal septum (DNS) and improves nasal obstruction. Sphenopalatine ganglion block (SPGB) effectively reduces postoperative pain after septoplasty, but conclusive evidence is still lacking. This systematic review and meta-analysis aim to comprehensively evaluate the analgesic efficacy of SPGB in septoplasty patients.

Methods

We systematically searched PubMed/Medline, Scopus, Web of Science, Embase, and CENTRAL from inception to April 10th, 2024. Randomized controlled trials (RCTs) were assessed using the RoB-2 tool. The primary outcomes were postoperative pain scores, analgesic consumption, surgery duration, postoperative nausea and vomiting (PONV), and patient satisfaction. Continuous data were pooled as mean difference (MD), and dichotomous data as risk ratio (RR) with a 95% confidence interval (CI) using STATA software. Additionally, trial sequential analysis (TSA) was conducted.

Results

Three RCTs with 180 patients were included. Two RCTs had a 'low risk' of bias, while one RCT had 'some concerns'. The SPGB group had significantly lower postoperative pain within 24 hours compared to controls, particularly after particularly after 1-2 hours (MD = -1.85), 4-6 hours (MD = -2.02), 12 hours (MD = -2.14), and 24 hours (MD = -2.36) TSA confirmed the conclusive evidence. Analgesic use was significantly reduced in the SPGB group. No significant differences were observed in surgery duration or PONV rates between groups. Patient satisfaction was significantly higher in the SPGB group.

Conclusion

SPGB demonstrates efficacy and safety in managing postoperative pain in patients undergoing septoplasty for DNS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sphenopalatine Ganglion BlockPostoperative PainNasal SeptumHumansRhinoplastyPain Management

Autor:innen und Institutionen

  • Kuwait Institute for Medical Specializations (KIMS), Kuwait City, Kuwait.
  • College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
  • School of Medicine, Royal College of Surgeons, Dublin, Ireland.
  • College of Medicine, Arabian Gulf University, Manama, Kingdom of Bahrain.
  • Department of Special Surgery, Division of ORL-HNS, Jordan University of Science and Technology and King Abdullah University Hospital, Irbid, Jordan.

Zitieren

APA

Albazee, E., AlRajhi, B., Alfadhli, A., Alharran, A. M., & Al-Qudah, M. (2024). Sphenopalatine ganglion block for pain control after septoplasty: a systematic review and meta-analysis with trial sequential analysis. Rhinology Journal. https://doi.org/10.4193/rhin24.225

Vancouver

Albazee E, AlRajhi B, Alfadhli A, Alharran AM, Al-Qudah M. Sphenopalatine ganglion block for pain control after septoplasty: a systematic review and meta-analysis with trial sequential analysis. Rhinology Journal. 2024. doi:10.4193/rhin24.225

BibTeX
@article{Albazee2024,
  author = {Albazee, E and AlRajhi, B and Alfadhli, A and Alharran, A M and Al-Qudah, M},
  title = {Sphenopalatine ganglion block for pain control after septoplasty: a systematic review and meta-analysis with trial sequential analysis},
  journal = {Rhinology Journal},
  year = {2024},
  doi = {10.4193/rhin24.225}
}
Kostenlos starten →